DD

David Dobrosky

Chief Business Officer

Transition Bio, Inc.

New York, New York


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Transition Bio, Inc.
Industry
research
Employees
34.0
Seniority
C suite
Annual Revenue
2000000.0
Total Funding
108351426.0
Latest Funding
Other

Technologies

Outlook Microsoft Office 365 WordPress.org Mobile Friendly Google Tag Manager Apache Python

Keywords

biotechnology research drug discovery condensate technology molecular platform biomolecular condensates oncogenic signaling rna foci molecular screening high throughput screening drug development biophysical assays target validation cell imaging machine learning microfluidics novel therapies binding mechanisms therapeutic hypothesis rare diseases oncology programs ai-based discovery small molecule design biotechnology proteins neurodegenerative diseases target engagement sequestered biomolecules cellular processes disease mechanisms biomaterials serious diseases translational sciences pharmacology indication selection hit identification biophysics protein interactions high-content imaging health challenges biological targets chemistry genomics protein aggregation soft matter physics cellular homeostasis phase screening molecular lens transcriptional assemblies innovative therapeutics artificial intelligence information technology & services

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans